documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

7 rows where agency_id = "FDA" and docket_id = "FDA-2004-E-0082" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 3

document_type 3

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2004-E-0082-0007 FDA Patent Extension for Uroxatral (Alfuzosin hydrochloride), U.S. Patent No. 4,661,491 FDA-2004-E-0082 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Sanofi-Aventis U.S., LLC Rule Certificate Extending Patent Term 2007-04-20T04:00:00Z 2007 4     2025-11-19T00:00:42Z   0 0 090000648046ede0
FDA-2004-E-0082-0006 FDA Patent Extension for Uroxatral (Alfuzosin hydrochloride), U.S. Patent No. 4,661,491 FDA-2004-E-0082 Letter from FDA CDER to the U.S. Patent and Trademark Office Other Letter(s) 2007-01-11T05:00:00Z 2007 1     2025-11-18T23:59:11Z   0 0 090000648046eddf
FDA-2004-E-0082-0005 FDA Patent Extension for Uroxatral (Alfuzosin hydrochloride), U.S. Patent No. 4,661,491 FDA-2004-E-0082 Determination of Regulatory Review Period for Purposes of Patent Extension; UROXATRAL Notice General Notice 2006-07-25T04:00:00Z 2006 7 2006-06-13T04:00:00Z   2025-11-18T23:55:43Z E6-9201 0 0 090000648046edde
FDA-2004-E-0082-0003 FDA Patent Extension for Uroxatral (Alfuzosin hydrochloride), U.S. Patent No. 4,661,491 FDA-2004-E-0082 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2006-05-25T04:00:00Z 2006 5     2025-11-18T23:49:14Z   0 0 090000648046eddb
FDA-2004-E-0082-0004 FDA Patent Extension for Uroxatral (Alfuzosin hydrochloride), U.S. Patent No. 4,661,491 FDA-2004-E-0082 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2006-05-25T04:00:00Z 2006 5     2025-11-18T23:51:51Z   0 0 090000648046eddc
FDA-2004-E-0082-0002 FDA Patent Extension for Uroxatral (Alfuzosin hydrochloride), U.S. Patent No. 4,661,491 FDA-2004-E-0082 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2004-10-22T04:00:00Z 2004 10     2025-11-18T23:45:53Z   0 0 090000648046edda
FDA-2004-E-0082-0001 FDA Patent Extension for Uroxatral (Alfuzosin hydrochloride), U.S. Patent No. 4,661,491 FDA-2004-E-0082 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2004-09-02T04:00:00Z 2004 9     2025-11-18T23:43:41Z   0 0 090000648046edd3

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);